New CDER appointment elevates longtime GLP-1 reviewer

July 6, 2026 01:05 PM EDT PeopleFDA+GLP-1 drugs New act­ing deputy CDER pro­mo­tion el­e­vates long­time GLP-1 re­view­er Max Bayer Senior Reporter Act­ing FDA CDER di­rec­tor Michael Davis has pro­mot­ed a long­time FDA staffer as an act­ing deputy di­rec­tor at the drug cen­ter. Lisa Yanoff, an agency … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER